Page 10 of 19 · 444 questions tagged titration.
Setup, so nobody has to ask: ESSENCE · 4 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
What I have: STEP 8 · 40 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s interpretation…
Conditions: STEP 8 · 30 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
This came up because two published schedules for the same agent differ. I have read the primary source rather than the summary, which has left me with more questions.…
For reference: fatigue · five · a GLP-1 receptor agonist. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than…
Details up front: SURMOUNT-4 · 40 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Concretely: early satiety · six · dulaglutide. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
Concretely: 40 mg · twelve weeks · hair thinning. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
Conditions: SURMOUNT-1 · injection-site erythema · 20 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading…
The particulars: FLOW · 20 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
Numbers first: vomiting · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
The specifics, since they change the answer: SURMOUNT-5 · headache · 2 mg. I have the document in front of me and I can read the numbers. What I cannot do is…
I have read the prescribing information and it addresses the adjacent case but not this one. I can parse the result. I am less sure what it licenses me to conclude. I…
Conditions: SURPASS-3 · dizziness · 60 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The receptor pharmacology I can follow; the in vivo translation is where I lose the thread. Please show the division. I want to check my own against yours. I would…
The specifics, since they change the answer: SURMOUNT-1 · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
I keep seeing people reason like this: oral semaglutide 14 mg daily is 98 mg a week, injectable is 2.4 mg a week, therefore the oral dose is roughly 40 times higher,…
The particulars: eight weeks · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
I am asking mechanistically rather than practically — I want the model, not the protocol. I would rather understand the derivation than memorise the outcome. Two…
Stated plainly: nausea · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear that…
Conditions: 10 mg · twelve weeks · hair thinning. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
Setup, so nobody has to ask: SURPASS-3 · injection-site erythema · 40 mg. I have read the primary source rather than the summary, which has left me with more…
Details up front: 2 mg · sixteen weeks · vomiting. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
The case in front of me: constipation · liraglutide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…